Abnormal T cell receptor V gene usage in myasthenia gravis: Prevalence and characterization of expanded T cell populations

Clinical and Experimental Immunology

Volumn 113, Issue 3, 1998, Pages 456-464

  Xu, B Y ^a   Giscombe, R ^a   Soderlund A ^c   Troye Blomberg, M ^c   Pirskanen, R ^b   Lefvert, A K ^a,b  

^a Center for Molecular Medicine   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Activation marker; Cytokine; Cytokine secretion; mRNA expression; Myasthenia gravis; T cell receptor

Indexed keywords

CD28 ANTIGEN; CD57 ANTIGEN; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HLA SYSTEM; HUMAN; HUMAN CELL; MALE; MYASTHENIA GRAVIS; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION;

ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0031657075     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00675.x     Document Type: Article

References (39)

1. Grunewald J, Wigzell H. T-cell expansions in healthy individuals. The Immunologist 1996; 4:99-103.
2. Meinl E, Weber F, Drexler K et al. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. J Clin Invest 1993; 92:2633-43.
3. Yamomoto K, Sakoda H, Nakajima T et al. Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int Immunol 1992; 4:1219-23.
4. + T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci USA 1994; 91:4965-9.
5. + T cell expansions using selected TCR V and J gene segments at the onset of giant cell arteritis. Arthritis Rheum 1994; 37:1221-7.
6. Giscombe R, Grunewald J, Nityanand S, Lefvert AK. T cell receptor V gene usage in patients with systemic necrotizing vasculitis. Clin Exp Immunol 1995; 101:213-9.
7. Nityanand S, Giscombe R, Srivastava S, Hjelmström P, Sanjeevi CB, Sinha N, Grunewald J, Lefvert AK. A bias in the αβ T cell receptor variable region gene usage in Takayasu's arteritis. Clin Exp Immunol 1997; 107:261-8.
8. Grunewald J, Åhlberg R, Lefvert AK. Dersimonian H, Wigzell H, Janson CH. Abnormal T-cell expansion and V-gene usage in myasthenia gravis patients. Scand J Immunol 1991; 34:161-8.
9. + T cell subsets of myasthenia gravis patients: a role for superantigen(s)? Mol Med 1996; 2:452-9.
10. Hjelmström P, Giscombe R, Lefvert AK, Grunewald J, Pirskanen R, Sanjeevi CB. HLA-DQ associations and T-cell receptor V-gene usage in peripheral blood of Swedish myasthenia gravis patients. Eur J Immunogenet 1997; 24:179-89.
11. + T cells in myasthenia gravis. J Autoimmun 1997; 10:203-17.
12. Infante AJ, Levcovitz H, Gordon V, Wall KA, Thompson PA, Krolick KA. Preferential use of a T cell receptor Vβ gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice. J Immunol 1992; 148:3385-90.
13. Pierce JL, Zborowski KA, Kraig E, Infante AJ. Highly conserved TCR β chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis. Int Immunol 1994; 6:775-83.
14. b strains. J Immunol 1995; 154:3603-10.
15. Smith LR, Kono DH, Asthana D, Balderas RS, Fujii Y, Lindström J. Theofilopoulos AN. T cell receptor V beta 15 dominates the anti-acetylcholine receptor response in Lewis rat T cell lines. J Immunol 1994; 152:2596-600.
16. Oosterhuis HHGH. Studies in myasthenia gravis. Part 1. A clinical study of 180 patients. J Neurol Sci 1964; 1:512-46.
17. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21 (Suppl. 94):23.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
19. Yi Q, Åhlberg R, Pirskanen R, Lefvert AK. Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells. J Neuroimmunol 1994; 50:177-86.
20. Posnett DN, Vissinga CS, Pambuccian C, Wei S, Robinson MA, Kostyu D, Concannon P. Level of human TCRBV3S1 (Vβ3) expression correlates with allelic polymorphism in the spacer region of the recombination signal sequence. J Exp Med 1994; 179:1707-11.
21. Posnett D, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to 'Benign Monoclonal Gammapathy'. J Exp Med 1994; 179:609-18.
22. Moss P, Gillespie G, Frodsham P, Reyburn H, Bell J. Analysis of clonal expansions within CD4 and CD8 T cells. The Immunologist 1996; 4:104-5.
23. + T cells contain cells with levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells. J Immunol 1993; 150:429-37.
24. Lanier LL, O'Fallon S, Somoza C, Phillips JH, Linsley PS, Okumura K, Ito D, Azuma M. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995; 154:97-105.
25. Jenkins MK, Johnson JG. Molecules involved in T-cell costimulation. Curr Opin Immunol 1993; 5:361-7.
26. Noel PJ, Boise LH, Green JM, Thompson CB. CD28 costimulation prevents cell death during primary T cell activation. J Immunol 1996; 157:636-42.
27. Abo T, Balch CM. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (NHK-1). J Immunol 1981; 127:1024-9.
28. Lanier LL, Loken MR. Human lymphocyte subpopulations identified by using three-color immunofluorescence and flow cytometry analysis: correlation of Leu-2, Leu-3, Leu-7, Leu-8 and Leu-11 cell surface antigen expression. J Immunol 1984; 132:151-6.
29. Kunemund V, Jungalwala FB, Fischer G, Chou DKH, Keilhauer G, Schachner M. The L2/HNK-1 carbohydrate of neutral cell adhesion molecules is involved in cell interactions. J Cell Biol 1988; 106:213-23.
30. Hoffman S, Edelman GM. A proteoglycan with HNK-1 antigenic determinants is a neuron-associated ligand for cytotactin. Proc Natl Acad Sci USA 1987; 84:2523-7.
31. + cells in normal healthy individuals: correlations with HCMV carrier status, phenotypic and functional analyses. Clin Exp Immunol 1993; 94:297-306.
32. Gratama LW, Kardol M, Naipal AMIH et al. The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity. Clin Exp Immunol 1987; 69:16-24.
33. Lewis DE, Puck JF, Babcock GF, Rich RR. Disproportionate expansion of a minor T cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome. J Infect Dis 1985; 151:555-9.
34. + cells in acquired immunodeficiency syndrome (AIDS). AIDS-related complex and asymptomatic homosexuals. J Clin Immunol 1986; 6:502-9.
35. + cells in rheumatoid arthritis synovial fluid. Arthritis Rheum 1992; 35:865-73.
36. Chan WC, Link S, Mawle A, Check I, Brynes RK, Winton EF. Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes. Blood 1986; 68:1142-53.
37. + T cell subsets in chronic lymphocytic leukemia. J Immunol 1997; 158:1482-9.
38. Butch AW, Chung GH, Nahm JHH. Cytokine expression by germinal center cells. J Immunol 1993; 150:39-47.
39. + T-cell expansions contribute to the unbalanced T cell receptor repertoire of rheumatoid arthritis patients. Blood 1997; 89:2822-32.